Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Celgene Corporation (CELG)

2014-11-26@15:25:27 ET
Celgene: The Winning Streak Continues (CELG) (F71)

2014-11-26@11:39:14 ET
Celgene (CELG) Approaches New Upside Target of $112.92 (PSM)

2014-11-26@10:35:22 ET
Next Resistance Level for Celgene (CELG) is $112.92 (F79)

2014-11-25@08:05:39 ET
Celgene Receives Positive CHMP Opinion for OTEZLA(R) (apremilast), the First Oral PDE4 Inhibitor for the Treatment of Patients with Psoriasis and Psoriatic Arthritis (ABW)

2014-11-24@16:46:43 ET
Celgene Rises 2.57% on Heavy Volume: Watch For Potential Pullback (PSM)

2014-11-24@16:46:12 ET
After Yesterday's Rally of 2.57% Shares Could Potentially Pullback (PSM)

2014-11-24@15:21:26 ET
Celgene: 52-Week High Recently Eclipsed (CELG) (F71)

2014-11-24@13:48:46 ET
Stock Investors Bid Up Shares of Celgene, Up 2.4% (F77)

2014-11-21@10:53:37 ET
Celgene (CELG) Crosses Pivot Point Resistance at $108.31 (F79)

2014-11-21@09:42:37 ET
Oral OTEZLA(R) (Apremilast) Showed Sustained Clinical Response over Two Years in Patients with Active Psoriatic Arthritis (ABW)

2014-11-21@06:00:05 ET
Celgene Receives Positive CHMP Opinion for OTEZLA(R) (apremilast), the First Oral PDE4 Inhibitor for the Treatment of Patients with Psoriasis and Psoriatic Arthritis (BIZ)

2014-11-20@10:56:14 ET
Celgene Shares Up 12.6% Since SmarTrend's Buy Recommendation (CELG) (PSM)

2014-11-20@08:00:05 ET
Chef Michael Ferraro, the Pancreatic Cancer Action Network and Meals to Heal Team up with Celgene to Address Nutritional Needs and Challenges Faced by Pancreatic Cancer Patients and Caregivers (BIZ)

2014-11-18@14:18:10 ET
Buyers Accumulate Shares of Celgene, Up 2.3% (F77)